Glutathione system in animal model of solid tumors: From regulation to therapeutic target

Critical Reviews in Oncology/Hematology

Volumn 128, Issue , 2018, Pages 43-57

  Corso, Claudia Rita ^a   Acco, Alexandra ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cancer therapeutic; Glutathione; Oxidative stress; Preclinical models; Solid tumors

Indexed keywords

3 METHYLCHOLANTHRENE; ARSENIC TRIOXIDE; AZATHIOPRINE; BRUSATOL; BUTHIONINE SULFOXIMINE; CANFOSFAMIDE; CARBOPLATIN; CISPLATIN; CISPLATIN DERIVATIVE; CYCLOPHOSPHAMIDE; DIMETHYLBENZ[A]ANTHRACENE; DISULFIRAM; DOCETAXEL; DOXORUBICIN; EZATIOSTAT; GEMCITABINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GOLD NANOPARTICLE; IMEXON; MELPHALAN; NOV 002; PACLITAXEL; REACTIVE OXYGEN METABOLITE; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VINORELBINE TARTRATE; ANTINEOPLASTIC AGENT;

APOPTOSIS; BREAST CANCER; CANCER RESISTANCE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CT26 CELL LINE; EHRLICH ASCITES TUMOR; FIBROSARCOMA; GLIOBLASTOMA; GLIOMA; GLUTATHIONE METABOLISM; HEMATOLOGIC MALIGNANCY; HUMAN; HYDROLYSIS; IMMUNOREGULATION; LEUKEMIA; LIVER CELL CARCINOMA; LLC-WRC 256 CELL LINE; LUNG CANCER; LYMPHOMA; MELANOMA; MYELODYSPLASTIC SYNDROME; MYELOMA; NEUROBLASTOMA; NON SMALL CELL LUNG CANCER; NONHUMAN; OVARY CANCER; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SARCOMA 180 CELL LINE; SOLID MALIGNANT NEOPLASM; TUMOR REGRESSION; TUMOR XENOGRAFT; UTERINE TUBE CARCINOMA; ANIMAL; DISEASE MODEL; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; GLUTATHIONE; HUMANS; NEOPLASMS; OXIDATIVE STRESS;

EID: 85048492179     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2018.05.014     Document Type: Review

References (201)

1. Acco, A., Bastos-Pereira, A.L., Dreifuss, A.A., Characteristics and applications of the walker-256 rat tumour. Pandalai, S.G., Pouliquen, Daniel, (eds.) The Rat in Cancer Research: A Crucial Tool for All Aspects of Translational Studies, 1 ed, 2012 Trivandrum Res. Signpost/ Transw. Res. Netw.
2. Agrawal, A., Chandra, D., Kale, R.K., Radiation induced oxidative stress: II studies in liver as a distant organ of tumor bearing mice. Mol. Cell. Biochem. 224 (2001), 9–17, 10.1023/A:1011990704575.
3. Agrawal, A., Jahan, S., Soyal, D., Goyal, E., Goyal, P.K., Amelioration of chemical-induced skin carcinogenesis by aegle marmelos, an Indian medicinal plant, fruit extract. Integr. Cancer Ther. 11 (2012), 257–266, 10.1177/1534735411417127.
4. Ainbinder, E., Bergelson, S., Daniel, V., Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene. Recept. Signal Transduct. 7 (1997), 279–289.
5. Akao, Y., Nakagawa, Y., Akiyama, K., Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455 (1999), 59–62.
6. Al-Harbi, M.M., Quereshi, S., Raza, M., Ahmed, M.M., Giangreco, A.B., Shak, A.H., Anticarcinogenic effect of Commiphora molmol on solid tumors induced by ehrlich carcinoma cells in mice. Exp. Chemother. 40 (1994), 337–347, 10.1017/CBO9781107415324.004.
7. Ali, D.A., El-Din, N.K.B., Abou-El-magd, R.F., Antioxidant and hepatoprotective activities of grape seeds and skin against Ehrlich solid tumor induced oxidative stress in mice. Egypt. J. Basic Appl. Sci. 2 (2015), 98–109, 10.1016/j.ejbas.2015.02.003.
8. Ali, H., Dixit, S., Quercetin attenuates the development of 7,12-dimethylbenz(a)anthracene (DMBA) and croton oil-induced skin cancer in mice. J. Biomed. Res. 29 (2015), 139–144, 10.7555/JBR.29.20130025.
9. Alves de Souza, C.E., Alves de Souza, H.D.M., Stipp, M.C., Corso, C.R., Galindo, C.M., Cardoso, C.R., Dittrich, R.L., de Souza Ramos, E.A., Klassen, G., Carlos, R.M., Correia Cadena, S.M.S., Acco, A., Ruthenium complex exerts antineoplastic effects that are mediated by oxidative stress without inducing toxicity in Walker-256 tumor-bearing rats. Free Radic. Biol. Med., 110, 2017, 10.1016/j.freeradbiomed.2017.06.011.
10. Anderton, B., Camarda, R., Balakrishnan, S., Balakrishnan, A., Kohnz, R.A., Lim, L., Evason, K.J., Momcilovic, O., Kruttwig, K., Huang, Q., Xu, G., Nomura, D.K., Goga, A., MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer. EMBO Rep. 18 (2017), 569–585, 10.15252/embr.201643068.
11. Anis, K.V., Rajeshkumar, N.V., Kuttan, R., Inhibition of chemical carcinogenesis by berberine in rats and mice. J. Pharm. Pharmacol. 53 (2001), 763–768, 10.1211/0022357011775901.
12. Aquilano, K., Baldelli, S., Ciriolo, M.R., Glutathione: new roles in redox signaling for an old antioxidant. Front. Pharmacol. 5 (2014), 1–12, 10.3389/fphar.2014.00196.
13. Argilés, J.M., López-Soriano, F.J., The energy state of tumor-bearing rats. J. Biol. Chem. 266 (1991), 2978–2982.
14. Armstrong, J.S., Jones, D.P., Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in HL60 cells that overexpress Bcl2. FASEB J. 16 (2002), 1263–1265, 10.1096/fj.02-0097fje.
15. Bailey, H.H., Ripple, G., Tutsch, K.D., Arzoomanian, R.Z., Alberti, D., Feierabend, C., Mahvi, D., Schink, J., Pomplun, M., Mulcahy, R.T., Wilding, G., Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan. J. Natl. Cancer Inst. 89 (1997), 1789–1796.
16. Ballatori, N., Krance, S.M., Notenboom, S., Shi, S., Tieu, K., Hammond, C.L., Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 390 (2009), 191–214, 10.1515/BC.2009.033.Glutathione.
17. Barr, P.M., Miller, T.P., Friedberg, J.W., Peterson, D.R., Baran, A.M., Herr, M., Spier, C.M., Cui, H., Roe, D.J., Persky, D.O., Casulo, C., Littleton, J., Schwartz, M., Puvvada, S., Landowski, T.H., Rimsza, L.M., Dorr, R.T., Fisher, R.I., Bernstein, S.H., Briehl, M.M., Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood 124 (2014), 1259–1265, 10.1182/blood-2014-04-570044.
18. Barreiros, A.L.B.S., David, J.M., David, J.P., Estresse oxidativo: Relação entre geração de espécies reativas e defesa do organismo. Quim. Nova 29 (2006), 113–123, 10.1590/S0100-40422006000100021.
19. Bastos-Pereira, A.L., Lugarini, D., de Oliveira-Christoff, A., Ávila, T.V., Teixeira, S., Pires, A.D.R.A., Muscará M.N., Cadena, S.M.S.C., Donatti, L., De Assis, H.C., da, S., Acco, A., Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism. Cancer Chemother. Pharmacol. 65 (2010), 267–276, 10.1007/s00280-009-1031-8.
20. Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M., Zupi, G., Biroccio, A., c-Myc phosphorylation is required for cellular response to oxidative stress. Mol. Cell 21 (2006), 509–519, 10.1016/j.molcel.2006.01.009.
21. Benhar, M., Shytaj, I.L., Stamler, J.S., Savarino, A., Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J. Clin., 126, 2016, 10.1172/JCI85339.treatment.
22. Bhattacharya, S., Haldar, P.K., Chemopreventive property of Trichosanthes dioica root against 3-methylcholanthrene-induced carcinogenesis in albino mice. J. Environ. Pathol. Toxicol. Oncol. 31 (2012), 109–119.
23. Burkitt, M.J., Bishop, H.S., Milne, L., Tsang, S.Y., Provan, G.J., Nobel, C.S.I., Orrenius, S., Slater, A.F.G., Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch. Biochem. Biophys. 353 (1998), 73–84.
24. Cao, Y., Wang, J., Henry-Tillman, R., Klimberg, V.S., Effect of 7,12-dimethylbenz[a]anthracene (DMBA) on gut glutathione metabolism. J. Surg. Res. 100 (2001), 135–140, 10.1006/jsre.2001.6229.
25. Carter, D.R., Sutton, S.K., Pajic, M., Murray, J., Sekyere, E.O., Fletcher, J., Beckers, A., Preter, K.De, Speleman, F., George, R.E., Haber, M., Norris, M.D., Cheung, B.B., Marshall, G.M., Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis. Mol. Oncol. 10 (2016), 866–878.
26. Cen, D., Brayton, D., Shahandeh, B., Meyskens, F.L., Farmer, P.J., Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J. Med. Chem. 47 (2004), 6914–6920, 10.1021/jm049568z.
27. Chen, D., Chan, R., Waxman, S., Jing, Y., Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH 2-terminal kinase and up-regulation of death receptors. Cancer Res. 66 (2006), 11416–11423, 10.1158/0008-5472.CAN-06-0409.
28. Chithrani, B.D., Jelveh, S., Jalali, F., van Prooijen, M., Allen, C., Bristow, R.G., Hill, R.P., Jaffray, D.A., Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat. Res. 173 (2010), 719–728, 10.1667/RR1984.1.
29. Choi, E.J., Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sci. 82 (2008), 1059–1064, 10.1016/j.lfs.2008.03.002.
30. Cohen, S.J., Zalupski, M.M., Conkling, P., Nugent, F., Ma, W.W., Modiano, M., Pascual, R., Lee, F.C., Wong, L., Hersh, E., A phase 2 randomized, double-blind, multicenter trial of imexon plus gemcitabine versus gemcitabine plus placebo in patients with metastatic chemotherapy-naïve pancreatic adenocarcinoma. Am. J. Clin. Oncol., 2015, 1–6, 10.1097/COC.0000000000000260.
31. Cohen, S.J., Zalupski, M.M., Modiano, M.R., Conkling, P., Patt, Y.Z., Davis, P., Dorr, R.T., Boytim, M.L., Hersh, E.M., A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer. Cancer Chemother. Pharmacol. 66 (2010), 287–294, 10.1007/s00280-009-1162-y.
32. Cruz, B., Gomes-Marcondes, M.C.C., Leucine-rich diet supplementation modulates foetal muscle protein metabolism impaired by Walker-256 tumour. Reprod. Biol. Endocrinol. 12 (2014), 2–10, 10.1186/1477-7827-12-2.
33. Cui, B.K., Liu, S., Li, S.H., Wang, J., Wang, Q.B., Li, S.P., Lin, X.J., Effect of tea polyphenol on oxidative injury in S180 cells induced hepatocarcinoma mice. Int. J. Mol. Sci. 13 (2012), 5571–5583, 10.3390/ijms13055571.
34. Cui, J., Shen, Y., Li, R., Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol. Med. 19 (2013), 197–209, 10.1016/j.molmed.2012.12.007.
35. Daga, M., Ulllio, C., Argenziano, M., Dianzani, C., Cavalli, R., Trotta, F., Ferretti, C., Zara, G.P., Gigliotti, C., Ciamporcero, E.S., Pettazzoni, P., Corti, D., Pizzimenti, S., Barrera, G., GSH-target nanosponges increase doxorubicin-induced toxicity in vitro and in vivo in cancer cells with high antioxidant defenses. Free Radic. Biol. Med. 97 (2016), 24–37, 10.1016/j.freeradbiomed.2016.05.009.
36. Daicoviciu, D., Filip, A.G., Ion, R.M., Clichici, S., Decea, N., Muresan, A., Oxidative photodamage induced by photodynamic therapy with methoxyphenyl porphyrin derivatives in tumour-bearing rats. Folia Biol. (Praha) 57 (2011), 12–19.
37. Dalle-Donne, I., Rossi, R., Colombo, G., Giustarini, D., Milzani, A., Protein S -glutathionylation: a regulatory device from bacteria to humans. Trends Biochem. Sci. 34 (2009), 85–96, 10.1016/j.tibs.2008.11.002.
38. Davies, K.J.A., The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48 (1999), 41–47, 10.1080/713803463.
39. Deminice, R., Cella, P.S., Padilha, C.S., Borges, F.H., da Silva, L.E.C.M., Campos-Ferraz, P.L., Jordao, A.A., Robinson, J.L., Bertolo, R.F., Cecchini, R., Guarnier, F.A., Creatine supplementation prevents hyperhomocysteinemia, oxidative stress and cancer-induced cachexia progression in Walker-256 tumor-bearing rats. Amino Acids 48 (2016), 2015–2024, 10.1007/s00726-016-2172-9.
40. Dethlefsen, L.A., Lehman, C.M., Biaglow, J.E., Peck, V.M., Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells. Radiat. Res. 114 (1988), 215–224.
41. Domenicotti, C., Marengo, B., Verzola, D., Garibotto, G., Traverso, N., Patriarca, S., Maloberti, G., Cottalasso, D., Poli, G., Passalacqua, M., Melloni, E., Pronzato, M.A., Marinari, U.M., Role of PKC-δ activity in glutathione-depleted neuroblastoma cells. Free Radic. Biol. Med. 35 (2003), 504–516, 10.1016/S0891-5849(03)00332-0.
42. Dorr, R.T., Raymond, M.A., Landowski, T.H., Roman, N.O., Fukushima, S., Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines. Int. J. Gastrointest. Cancer 36 (2005), 15–28, 10.1385/IJGC:36:1:015.
43. Dragovich, T., Gordon, M., Mendelson, D., Wong, L., Modiano, M., Chow, H.-H.S., Samulitis, B., O'Day, S., Grenier, K., Hersh, E., Dorr, R., Phase I trial of imexon in patients with advanced malignancy. J. Clin. Oncol. 25 (2007), 1779–1784, 10.1200/JCO.2006.08.9672.
44. Dreifuss, A.A., Bastos-Pereira, A.L., Ávila, T.V., Soley, B., da, S., Rivero, A.J., Aguilar, J.L., Acco, A., Antitumoral and antioxidant effects of a hydroalcoholic extract of cat's claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model. J. Ethnopharmacol. 130 (2010), 127–133, 10.1016/j.jep.2010.04.029.
45. Dreifuss, A.A., Bastos-Pereira, A.L., Fabossi, I.A., Stolf, A.M., Souza, C.E.A., de, Gomes, Lde O., Costantin, R.P., Furman, A.E.F., Strapasson, R.L.B., Teixeira, S., Zampronio, A.R., Muscará M.N., Stefanello, M.E.A., Acco, A., Uncaria tomentosa exerts extensive anti-neoplastic effects against the walker-256 tumour by modulating oxidative stress and not by alkaloid activity. PLoS One 8 (2013), 1–14, 10.1371/journal.pone.0054618.
46. Dröge, W., Pottmeyer-Gerber, C., Schmidt, H., Nick, S., Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 172 (1986), 151–156.
47. Dvorakova, K., Payne, C.M., Tome, M.E., Briehl, M.M., McClure, T., Dorr, R.T., Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon. Biochem. Pharmacol. 60 (2000), 749–758.
48. Dvorakova, K., Waltmire, C.N., Payne, C.M., Tome, M.E., Briehl, M.M., Dorr, R.T., Induction of mitochondrial changes in myeloma cells by imexon. Blood 97 (2001), 3544–3551.
49. El-Mofty, M.M., Abdelmeguid, N.E., Sadek, I.A., Essawy, A.E., Aleem, E.A., Induction of leukaemia in chloramphenicol-treated toads. East. Mediterr. Health J. 6 (2000), 1026–1034.
50. Estrela, J.M., Ortega, A., Obrador, E., Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 43 (2006), 143–181.
51. Fahim, F.A., Esmat, A.Y., Mady, E.A., Ibrahim, E.K., Antitumor activities of iodoacetate and dimethylsulphoxide against solid Ehrlich carcinoma growth in mice. Biol. Res. 36 (2003), 253–262, 10.4067/S0716-97602003000200015.
52. FDA, Food and Drug Administration. Acessed April 3, 2018. URL, 2018 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209780.
53. Fernandes, R.S., Cotter, T.G., Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem. Pharmacol. 48 (1994), 675–681, 10.1016/0006-2952(94)90044-2.
54. Findlay, V.J., Townsend, D.M., Saavedra, J.E., Buzard, G.S., Citro, M.L., Keefer, L.K., Ji, X., Tew, K.D., Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol. Pharmacol. 65 (2004), 1070–1079, 10.1124/mol.65.5.1070.
55. Firdous, A.P., Sindhu, E.R., Ramnath, V., Kuttan, R., Anticarcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action. Nutr. Cancer, 2013, 10.1080/01635581.2013.801501.
56. Fonslow, B.R., Stein, B.D., Webb, K.J., Xu, T., Choi, J., Kyu, S., Iii, J.R.Y., Phase 2 study of neoadjuvant treatment with nov-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II- IIIc breast cancer. Breast Cancer Res. Treat. 132 (2012), 215–223, 10.1038/nmeth.2250.Digestion.
57. Forman, H.J., Zhang, H., Rinna, A., Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Asp. Med. 30 (2010), 1–12, 10.1016/j.mam.2008.08.006.Glutathione.
58. Fraternale, A., Paoletti, M.F., Casabianca, A., Oiry, J., Clayette, P., Vogel, J.-U., Cinatl, J.J., Palamara, A.T., Sgarbanti, R., Garaci, E., Millo, E., Benatti, U., Magnani, M., Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules. Curr. Med. Chem. 13 (2006), 1749–1755.
59. Freitas, J.J., Pompéia, C., Miyasaka, C.K., Curi, R., Walker-256 tumor growth causes oxidative stress in rat brain. J. Neurochem. 77 (2001), 655–663.
60. Gallogly, M.M., Mieyal, J.J., Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol. 7 (2007), 381–391, 10.1016/j.coph.2007.06.003.
61. Galuppo, L.F., Lívero, F.Ados R., Martins, G.G., Cardoso, C.C., Beltrame, O.C., Klassen, L.M.B., Canuto, A.V., dos, S., Echevarria, A., Telles, J.E.Q., Klassen, G., Acco, A., Sydnone 1: A Mesoionic Compound with Anti-tumoural and Hematological Effects In Vivo. Basic Clin. Pharmacol. Toxicol. 119 (2016), 41–50, 10.1111/bcpt.12545.
62. Garcia-Ruiz, C., Fernández-Checa, J.C., Redox regulation of hepatocyte apoptosis. J. Gastroenterol. Hepatol. 22 (2007), S38–42, 10.1111/j.1440-1746.2006.04644.x.
63. Griffith, O.W., Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257 (1982), 13704–13712.
64. Griffith, W., Meister, A., Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-Butyl homocysteine sulfoximine). J. Biol. Chem. 254 (1979), 7558–7560.
65. Guarnier, F.A., Cecchini, A.L., Suzukawa, A.A., Maragno, A.L.G.C., Simão, A.N.C., Gomes, M.D., Cecchini, R., Time course of skeletal muscle loss and oxidative stress in rats with walker 256 solid tumor. Muscle Nerve 42 (2010), 950–958, 10.1002/mus.21798.
66. Gumireddy, K., Li, A., Cao, L., Yan, J., Liu, L., NOV-002, a glutathione disulfide mimetic, suppresses tumor cell invasion and metastasis. J. Carcinog. Mutagen S7 (2013), 997–1003, 10.4172/2157-2518.S7-002.
67. Hainfeld, J.F., Slatkin, D.N., Smilowitz, H.M., The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49 (2004), 309–315, 10.1088/0031-9155/49/18/N03.
68. Hall, A.G., The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 29 (1999), 238–245.
69. Hamilton, D., Batist, G., TLK-199 (Telik). IDrugs 8 (2005), 662–669.
70. Hamilton, T.C., Winker, M.A., Louie, K.G., Batist, G., Behrens, B.C., Tsuruo, T., Grotzinger, K.R., McKoy, W.M., Young, R.C., Ozols, R.F., Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem. Pharmacol. 34 (1985), 2583–2586, 10.1016/0006-2952(85)90551-9.
71. Han, D., Wu, G., Chang, C., Zhu, F., Xiao, Y., Li, Q., Zhang, T., Zhang, L., Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway. Oncotarget 6 (2015), 40907–40919, 10.18632/oncotarget.5723.
72. Han, Y.H., Park, W.H., The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione. Oncol. Rep. 22 (2009), 385–391.
73. Harris, E.D., Regulation of antioxidant enzymes. FASEB J. 6 (1992), 2675–2683.
74. Hayes, J.D., Flanagan, J.U., Jowsey, I.R., Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45 (2005), 51–88, 10.1146/annurev.pharmtox.45.120403.095857.
75. Hayes, J.D., McMahon, M., The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer. Mol. Cell 21 (2006), 732–734, 10.1016/j.molcel.2006.03.004.
76. Hayseda, J.D., Pulford, D.J., The glut athione S-transferase supergene family: regulation of GST and the contribution of the lsoenzymes to cancer chemoprotection and drug resistance part I. Crit. Rev. Biochem. Mol. Biol. 30 (1995), 445–520, 10.3109/10409239509083491.
77. Hernández-Breijo, B., Monserrat, J., Ramírez-Rubio, S., Cuevas, E.P., Vara, D., Díaz-Laviada, I., Fernández-Moreno, M.D., Román, I.D., Gisbert, J.P., Guijarro, L.G., Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. World J. Gastroenterol. 17 (2011), 3899–3911, 10.3748/wjg.v17.i34.3899.
78. Herzenberg, L.A., De Rosa, S.C., Dubs, J.G., Roederer, M., Anderson, M.T., Ela, S.W., Deresinski, S.C., Herzenber, L., Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 1967–1972.
79. Hochwald, S.N., Harrison Lawrence, E., Rose, D.M., Burt, M.E., y-Glutamyl Transpeptidase Mediation of Tumor Glutathione Utilization In vivo. J. Natl. Cancer Inst. 88 (1996), 193–197.
80. Huang, K.P., Huang, F.L., Glutathionylation of proteins by glutathione disulfide S-oxide. Biochem. Pharmacol. 64 (2002), 1049–1056, 10.1016/S0006-2952(02)01175-9.
81. Hwang, C., Sinskey, A.J., Lodish, H.F., Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257 (1992), 1496–1502, 10.1126/science.1523409.
82. Jahan, S., Chaudhary, R., Goyal, P.K., Anticancer activity of an Indian medicinal plant, alstonia scholaris, on skin carcinogenesis in mice. Integr. Cancer Ther. 8 (2009), 273–279, 10.1177/1534735409343590.
83. Jozefczak, M., Remans, T., Vangronsveld, J., Cuypers, A., Glutathione is a key player in metal-induced oxidative stress defenses. Int. J. Mol. Sci. 13 (2012), 3145–3175, 10.3390/ijms13033145.
84. Jumes, F.M.D., Lugarini, D., Pereira, A.L.B., de Oliveira, A., Christoff, A.D.O., Linde, G.A., do Valle, J.S., Colauto, N.B., Acco, A., Effects of agaricus brasiliensis mushroom in walker-256 tumor-bearing rats. Can. J. Physiol. Pharmacol. 88 (2010), 21–27, 10.1139/Y09-111.
85. Kandil, E., Aziz, N.A., Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice. Tumor Biol. 37 (2015), 1825–1834, 10.1007/s13277-015-3954-5.
86. Kaplowitz, N., Aw, T.Y., Ookhtens, M., The regulation of hepatic glutathione. Ann. Rev. Pharmacol. Toxicol. 25 (1985), 715–744.
87. Kaufmann, Y., Todorova, V.K., Luo, S., Klimberg, V.S., Glutamine affects glutathione recycling enzymes in a DMBA-induced breast cancer model. Nutr. Cancer 60 (2008), 518–525, 10.1080/01635580801956501.
88. Kavanagh, J.J., Gershenson, D.M., Choi, H., Lewis, L., Patel, K., Brown, G.L., Garcia, A., Spriggs, D.R., Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer. Int. J. Gynecol. Cancer 15 (2005), 593–600, 10.1111/j.1525-1438.2005.00114.x.
89. Kavanagh, J.J., Levenback, C.F., Ramirez, P.T., Wolf, J.L., Moore, C.L., Jones, M.R., Meng, L., Brown, G.L., Bast, R.C., Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer. J. Hematol. Oncol., 3, 2010, 9, 10.1186/1756-8722-3-9.
90. Kim, J.Y., Cho, Y., Oh, E., Lee, N., An, H., Sung, D., Cho, T.-M., Seo, J.H., Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer. Cancer Lett. 379 (2016), 39–48, 10.1016/j.canlet.2016.05.026.
91. Kim, Y., Maciag, A.E., Cao, Z., Deschamps, J.R., Saavedra, J.E., Keefer, L.K., Holland, R.J., PABA/NO lead optimization: improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cells. Bioorg. Med. Chem. 23 (2015), 4980–4988, 10.1016/j.bmc.2015.05.020.
92. Kogias, E., Osterberg, N., Baumer, B., Psarras, N., Koentges, C., Papazoglou, A., Saavedra, J.E., Keefer, L.K., Weyerbrock, A., Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas. Int. J. Cancer 130 (2012), 1184–1194, 10.1002/ijc.26106.
93. Kolberg, A., Rosa, T.G., Puhl, M.T., Scola, G., Janner, D.D.R., Maslinkiewicz, A., Lagranha, D.J., Heck, T.G., Curi, R., Homem De Bittencourt, P.I., Low expression of MRP1/GS-X pump ATPase in lymphocytes of Walker 256 tumour-bearing rats is associated with cyclopentenone prostaglandin accumulation and cancer immunodeficiency. Cell Biochem. Funct. 24 (2006), 23–39, 10.1002/cbf.1290.
94. König, J., Nies, A.T., Cui, Y., Leier, I., Keppler, D., Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta Biomembr. 1461 (1999), 377–394, 10.1016/S0005-2736(99)00169-8.
95. Kowaltowski, A.J., Fiskum, G., Redox mechanisms of cytoprotection by Bcl-2. Antioxid. Redox Signal. 7 (2008), 508–514, 10.1089/ars.2005.7.508.
96. Kumar, S.S., Karrunakaran, C.M., Rao, M.R.K., Balasubramanian, M.P., Inhibitory effects of Indigofera aspalathoides on 20-methylcholanthrene-induced chemical carcinogenesis in rats. J. Carcinog. 10 (2011), 1–18, 10.4103/1477-3163.75458.
97. Kumar, S.S., Karrunakaran, C.M., Rao, M.R.K., Balasubramanian, M.P., Indigofera aspalathoides, protection against 20-methylcholantherene-induced experimental fibrosarcoma growth after transplantation in rats-role of xenobiotic drug metabolizing enzymes. Asian Pac. J. Cancer Prev. 11 (2010), 1833–1838.
98. Kunze, T., Heps, S., Phosphono analogs of glutathione: inhibition of glutathione transferases, metabolic stability, and uptake by cancer cells. Biochem. Pharmacol. 59 (2000), 973–981, 10.1016/S0006-2952(99)00401-3.
99. Kushner, B.H., LaQuaglia, M.P., Wollner, N., Meyers, P.A., Lindsley, K.L., Ghavimi, F., Merchant, T.E., Boulad, F., Cheung, N.K., Bonilla, M.A., Crouch, G., Kelleher, J.F., Steinherz, P.G., Gerald, W.L., Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J. Clin. Oncol. 14 (1996), 1526–1531, 10.1002/pbc.
100. Lauterburg, B.H., Adams, J.D., Mitchell, J.R., Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology 4 (1984), 586–590.
101. Lee, C.K., Son, S.H., Park, K.K., Park, J.H., Lim, S.S., Chung, W.Y., Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. J. Pharmacol. Sci. 106 (2008), 444–451, 10.1254/jphs.FP0071498.
102. Lee, C.K., Son, S.H., Park, K.K., Park, J.H.Y., Lim, S.S., Kim, S.-H., Chung, W.Y., Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Basic Clin. Pharmacol. Toxicol. 103 (2008), 48–54, 10.1111/j.1742-7843.2008.00238.x.
103. Lee, J.R., Roh, J.-L., Lee, S.M., Park, Y., Cho, K.-J., Choi, S.-H., Nam, S.Y., Kim, S.Y., Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinoma. J. Cancer Res. Clin. Oncol., 2017, 10.1007/s00432-017-2466-7.
104. Lee, M., Hyun, D.H., Marshall, K.A., Ellerby, L.M., Bredesen, D.E., Jenner, P., Halliwell, B., Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free. Radic. Biol. Med. 31 (2001), 1550–1559.
105. Lee, S., Kang, J., Cho, M., Seo, E., Choi, H., Kim, E., Kim, J., Kim, H., Kang, G.U.M.Y., Kim, K.P.Y.O., Park, Y., Yu, D., Yum, Y.N.A., Park, S., Yoon, D., Profiling of transcripts and proteins modulated by K- ras oncogene in the lung tissues of K- ras transgenic mice by omics approaches. Int. J. Oncol. 34 (2009), 161–172, 10.3892/ijo.
106. Leier, I., Jedlitschky, G., Buchholz, U., Center, M., Cole, S.P., Deeley, R.G., Keppler, D., ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J. 314 (1996), 433–437.
107. Lew, Y.S., Brown, S.L., Griffin, R.J., Song, C.W., Kim, J.H., Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Res. 59 (1999), 6033–6037.
108. Lewis-Wambi, J.S., Swaby, R., Kim, H., Jordan, V.C., Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer. J. Steroid Biochem. Mol. Biol. 114 (2009), 33–39, 10.1016/j.jsbmb.2008.12.016.
109. Liu, X., Wang, L., Cui, W., Yuan, X., Lin, L., Cao, Q., Wang, N., Li, Y., Guo, W., Zhang, X., Wu, C., Yang, J., Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells. Oncotarget 7 (2016), 58516–58530, 10.18632/oncotarget.11305.
110. Liu, Y., Chang, Y., Yang, C., Sang, Z., Yang, T., Ang, W., Ye, W., Wei, Y., Gong, C., Luo, Y., Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities. Nanoscale 6 (2014), 4325–4337, 10.1039/c3nr06599e.
111. Louie, K.G., Behrens, B.C., Kinsella, T.J., Hamilton, T.C., Grotzinger, K.R., McKoy, W.M., Winker, M.A., Ozols, R.F., Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res. 45 (1985), 2110–2115.
112. Lu, J., Chew, E.-H., Holmgren, A., Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc. Natl. Acad. Sci. U. S. A 104 (2007), 12288–12293, 10.1073/pnas.0701549104.
113. Lu, S.C., Glutathione synthesis. Biochim. Biophys. Acta 1830 (2014), 3143–3153, 10.1016/j.bbagen.2012.09.008.GLUTATHIONE.
114. Lun, X., Wells, J.C., Grinshtein, N., King, J.C., Hao, X., Dang, N.-H., Wang, X., Aman, A., Uehling, D., Datti, A., Wrana, J.L., Easaw, J.C., Luchman, A., Weiss, S., Cairncross, J.G., Kaplan, D.R., Robbins, S.M., Senger, D.L., Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma. Clin. Cancer Res. 22 (2016), 3860–3875, 10.1158/1078-0432.CCR-15-1798.
115. Maeda, H., Hori, S., Nishitoh, H., Ichijo, H., Ogawa, O., Kakehi, Y., Kakizuka, A., Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61 (2001), 5432–5440.
116. Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., Kakizuka, A., Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ. 11 (2004), 737–746, 10.1038/sj.cdd.4401389.
117. Mahadevan, D., Sutton, G.R., Ezatiostat hydrochloride for the treatment of myelodysplastic syndromes. Expert Opin. Investig. Drugs 24 (2015), 725–733, 10.1517/13543784.2015.1021003.
118. Majed, F., Rashid, S., Khan, A.Q., Nafees, S., Ali, N., Ali, R., Khan, R., Hasan, S.K., Mehdi, S.J., Sultana, S., Tannic acid mitigates the DMBA/croton oil-induced skin cancer progression in mice. Mol. Cell. Biochem. 399 (2015), 217–228, 10.1007/s11010-014-2248-3.
119. Mannervik, B., Board, P.G., Hayes, J.D., Listowsky, I., Pearson, W.R., Nomenclature for mammalian soluble glutathione transferases. Methods Enzym. 401 (2005), 1–8.
120. Marí M., Morales, A., Colell, A., García-Ruiz, C., Fernández-Checa, J.C., Mitochondrial glutathione, a key survival antioxidant. Antioxid. Redox Signal. 11 (2009), 2685–2700, 10.1089/ars.2009.2695.
121. Markovic, J., Borrás, C., Ortega, A., Sastre, J., Viña, J., Pallardó F.V., Glutathione is recruited into the nucleus in early phases of cell proliferation. J. Biol. Chem. 282 (2007), 20416–20424.
122. Markovic, J., Mora, N.J., Broseta, A.M., Gimeno, A., De-la-Concepción, N., Viña, J., Pallardó F.V., The depletion of nuclear glutathione impairs cell proliferation in 3t3 fibroblasts. PLoS One 4 (2009), 1–14, 10.1371/journal.pone.0006413.
123. Martins, G.G., Lívero, F.A.D.R., Stolf, A.M., Kopruszinski, C.M., Cardoso, C.C., Beltrame, O.C., Queiroz-Telles, J.E., Strapasson, R.L.B., Stefanello, M.É.A., Oude-Elferink, R., Acco, A., Sesquiterpene lactones of moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats. Chem. Biol. Interact. 228 (2015), 46–56, 10.1016/j.cbi.2015.01.018.
124. Masella, R., Di Benedetto, R., Varì R., Filesi, C., Giovannini, C., Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 16 (2005), 577–586, 10.1016/j.jnutbio.2005.05.013.
125. Mata-Greenwood, E., Cuendet, M., Sher, D., Gustin, D., Stock, W., Pezzuto, J.M., Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc. Leukemia 16 (2002), 2275–2284, 10.1038/sj.leu.2402696.
126. Mathivadhani, P., Shanthi, P., Sachdanandam, P., Effect of Semecarpus anacardium Linn. Nut extract on mammary and hepatic expression of xenobiotic enzymes in DMBA-induced mammary carcinoma. Environ. Toxicol. Pharmacol. 23 (2007), 328–334, 10.1016/j.etap.2006.12.004.
127. Matsumaru, K., Ji, C., Kaplowitz, N., Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology 37 (2003), 1425–1434, 10.1053/jhep.2003.50230.
128. Meister, A., Anderson, M.E., Glutathione. Ann. Rev. Biochem. 52 (1983), 711–760.
129. Meister, A., Tate, S.S., Glutathione and related y-glutamyl compounds: biosynthesis and utilization. Annu. Rev. Biochem. 45 (1976), 559–604.
130. Miller, W.H., Schipper, H.M., Lee, J.S., Singer, J., Waxman, S., Mechanisms of action of arsenic trioxide. Cancer Res. 62 (2002), 3893–3903, 10.1056/nejm199811053391901.
131. Mills, B.J., Lindeman, R.D., Lang, C.A., Differences in blood glutathione levels of tumor-implanted or zinc-deficient rats. J. Nutr. 111 (1981), 1586–1592.
132. Miranda-Vilela, A.L., Grisolia, C.K., Longo, J.P.F., Peixoto, R.C.A., de Almeida, M.C., Barbosa, L.C.P., Roll, M.M., Portilho, F.A., Estevanato, L.L.C., Bocca, A.L., Báo, S.N., Lacava, Z.G.M., Oil rich in carotenoids instead of vitamins C and E as a better option to reduce doxorubicin-induced damage to normal cells of Ehrlich tumor-bearing mice: hematological, toxicological and histopathological evaluations. J. Nutr. Biochem. 25 (2014), 1161–1176, 10.1016/j.jnutbio.2014.06.005.
133. Moehler, T.M., Feneberg, R., Ho, A.D., Golenkov, A.K., Ludwig, H., Kropff, M., Khuageva, N.K., Hajda, J., von Broen, I., Goldschmidt, H., Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma. Anticancer Drugs 21 (2010), 708–715, 10.1097/CAD.0b013e32833b975b.
134. Monga, J., Aggarwal, V., Suthar, S.K., Monika, Nongalleima, K., Sharma, M., Topical (+)-catechin emulsified gel prevents DMBA/TPA-induced squamous cell carcinoma of the skin by modulating antioxidants and inflammatory biomarkers in BALB/c mice. Food Funct. 5 (2014), 3197–3207, 10.1039/c4fo00531g.
135. Morales, G.A., Laborde, E., Small-molecule inhibitors of glutathione S-transferase P1-1 as anticancer therapeutic agents. Chapter 20 Annu. Rep. Med. Chem. 42 (2007), 321–335, 10.1016/S0065-7743(07)42020-6.
136. Mougiakakos, D., Okita, R., Ando, T., Dürr, C., Gadiot, J., Ichikawa, J., Zeiser, R., Blank, C., Johansson, C.C., Kiessling, R., High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis. J. Mol. Med. 90 (2012), 935–944, 10.1007/s00109-012-0857-4.
137. Moulder, S., Dhillon, N., Ng, C., Hong, D., Wheler, J., Naing, A., Tse, S., La Paglia, A., Dorr, R., Hersh, E., Boytim, M., Kurzrock, R., A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. Invest. New Drugs 28 (2010), 634–640, 10.1007/s10637-009-9273-1.
138. Muqbil, I., Banu, N., Enhancement of pro-oxidant effect of 7,12-dimethylbenz (a) anthracene (DMBA) in rats by pre-exposure to restraint stress. Cancer Lett. 240 (2006), 213–220, 10.1016/j.canlet.2005.09.008.
139. Nechushtan, H., Hamamreh, Y., Nidal, S., Gotfried, M., Baron, A., Shalev, Y.I., Nisman, B., Peretz, T., Peylan-Ramu, N., A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. Oncologist 20 (2015), 366–367, 10.1634/theoncologist.2014-0424.
140. Noaman, E., El-Din, N.K.B., Bibars, M.A., Mossallam, A.A.A., Ghoneum, M., Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma. Cancer Lett. 268 (2008), 348–359, 10.1016/j.canlet.2008.04.012.
141. O'Dwyer, P.J., Hamilton, T.C., LaCreta, F.P., Gallo, J.M., Kilpatrick, D., Halbherr, T., Brennan, J., Bookman, M.A., Hoffman, J., Young, R.C., Comis, R.L., Ozols, R.F., Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J. Clin. Oncol. 14 (1996), 249–256.
142. Olayanju, A., Copple, I.M., Bryan, H.K., Edge, G.T., Sison, R.L., Wong, M.W., Lai, Z.-Q., Lin, Z.-X., Dunn, K., Sanderson, C.M., Alghanem, A.F., Cross, M.J., Ellis, E.C., Ingelman-Sundberg, M., Malik, H.Z., Kitteringham, N.R., Goldring, C.E., Park, B.K., Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic. Biol. Med. 78 (2015), 202–212, 10.1016/j.freeradbiomed.2014.11.003.
143. Ongaro, A., Pellati, A., De Mattei, M., De Terlizzi, F., Rossi, C.R., Campana, L.G., Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells. Anticancer Drugs 26 (2015), 284–292, 10.1097/CAD.0000000000000192.
144. Ozols, R.F., Louie, K.G., Plowman, J., Behrens, B.C., Fine, R.L., Dykes, D., Hamilton, T.C., Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem. Pharmacol. 36 (1987), 147–153, 10.1016/0006-2952(87)90392-3.
145. Pallardó F.V., Markovic, J., García, J.L., Viña, J., Role of nuclear glutathione as a key regulator of cell proliferation. Mol. Aspects Med. 30 (2009), 77–85, 10.1016/j.mam.2009.01.001.
146. Parmar, J., Sharma, P., Verma, P., Sharma, P., Goyal, P.K., Elimination of deleterious effects of DMBA-induced skin carcinogenesis in mice by Syzygium cumini seed extract. Integr. Cancer Ther. 10 (2011), 289–297, 10.1177/1534735410385112.
147. Pellny, T.K., Locato, V., Vivancos, P.D., Markovic, J., De Gara, L., Pallardó F.V., Foyer, C.H., Pyridine nucleotide cycling and control of intracellular redox state in relation to poly (ADP-ribose) polymerase activity and nuclear localization of glutathione during exponential growth of Arabidopsis cells in culture. Mol. Plant 2 (2009), 442–456, 10.1093/mp/ssp008.
148. Periyasamy, K., Baskaran, K., Ilakkia, A., Vanitha, K., Selvaraj, S., Sakthisekaran, D., Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats. Cancer Chemother. Pharmacol. 75 (2015), 263–272, 10.1007/s00280-014-2629-z.
149. Peterson, J.D., Herzenberg, L.A., Vasquez, K., Waltenbaugh, C., Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 3071–3076.
150. Pourpak, A., Meyers, R.O., Samulitis, B.K., Chow, H.S., Kepler, C.Y., Raymond, M.A., Hersh, E., Dorr, R.T., Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice. Anticancer Drugs 17 (2006), 1179–1184, 10.1097/01.cad.0000236305.43209.f0.
151. Rajakumar, T., Pugalendhi, P., Thilagavathi, S., Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats. Chem. Biol. Interact. 231 (2015), 35–43, 10.1016/j.cbi.2015.02.015.
152. Ramprasath, V.R., Shanthi, P., Sachdanandam, P., Effect of Semecarpus anacardium Linn. Nut milk extract on rat neutrophil functions in adjuvant arthritis.. J. Med. Food 9 (2006), 265–269, 10.1002/cbf.1243.
153. Raza, A., Galili, N., Smith, S.E., Godwin, J., Boccia, R.V., Myint, H., Mahadevan, D., Mulford, D., Rarick, M., Brown, G.L., Schaar, D., Faderl, S., Komrokji, R.S., List, A.F., Sekeres, M., A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome. Cancer 118 (2012), 2138–2147, 10.1002/cncr.26469.
154. Ren, D., Villeneuve, N.F., Jiang, T., Wu, T., Lau, A., Toppin, H.A., Zhang, D.D., Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 1433–1438, 10.1073/pnas.1014275108.
155. Rocha, C.R.R., Garcia, C.C.M., Vieira, D.B., Quinet, A., de Andrade-Lima, L.C., Munford, V., Belizário, J.E., Menck, C.F.M., Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis., 5, 2014, e1505, 10.1038/cddis.2014.465.
156. Rosa, L.F.B.P.C., Kazantzis, M., Seelaender, M.C.L., The effect of Walker-256 tumour development upon kupffer cell metabolism. Cell Biochem. Funct. 16 (1998), 195–202.
157. Rosen, L.S., Brown, J., Laxa, B., Boulos, L., Reiswig, L., Henner, W.D., Lum, R.T., Schow, S.R., Maack, C.A., Keck, J.G., Mascavage, J.C., Dombroski, J.A., Gomez, R.F., Brown, G.L., Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies. Clin. Cancer Res. 9 (2003), 1628–1638.
158. Rosen, L.S., Laxa, B., Boulos, L., Wiggins, L., Keck, J.G., Jameson, A.J., Parra, R., Patel, K., Brown, G.L., Phase 1 study of TLK286 (Telcyta) administered weekly in advanced malignancies. Clin. Cancer Res. 10 (2004), 3689–3698, 10.1158/1078-0432.CCR-03-0687.
159. Saavedra, J.E., Srinivasan, A., Buzard, G.S., Davies, K.M., Waterhouse, D.J., Inami, K., Wilde, T.C., Citro, M.L., Cuellar, M., Deschamps, J.R., Parrish, D., Shami, P.J., Findlay, V.J., Townsend, D.M., Tew, K.D., Singh, S., Jia, L., Ji, X., Keefer, L.K., PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. J. Med. Chem. 49 (2006), 1157–1164, 10.1021/jm050700k.
160. Samulitis, B.K., Landowski, T.H., Dorr, R.T., Correlates of imexon sensitivity in human multiple myeloma cell lines. Leuk. Lymphoma 47 (2006), 97–109, 10.1080/10428190500266210.
161. Samy, R.P., Rajendran, P., Li, F., Anandi, N.M., Stiles, B.G., Ignacimuthu, S., Sethi, G., Chow, V.T.K., Identification of a novel calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-kB pathway. PLoS One 7 (2012), 1–14, 10.1371/journal.pone.0048514.
162. Schafer, F.Q., Buettner, G.R., Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001), 1191–1212, 10.1016/S0891-5849(01)00480-4.
163. Seol, H.S., Lee, S.E., Song, J.S., Lee, H.Y., Park, S., Kim, I., Singh, S.R., Chang, S., Jang, S.J., Glutamate release inhibitor, riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production. Cancer Lett. 382 (2016), 157–165, 10.1016/j.canlet.2016.08.028.
164. Sequist, L.V., Fidias, P.M., Temel, J.S., Kolevska, T., Rabin, M.S., Boccia, R.V., Burris, H.A., Belt, R.J., Huberman, M.S., Melnyk, O., Mills, G.M., Englund, C.W., Caldwell, D.C., Keck, J.G., Meng, L., Jones, M., Brown, G.L., Edelman, M.J., Lynch, T.J., Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. J. Thorac. Oncol. 4 (2009), 1389–1396, 10.1097/JTO.0b013e3181b6b84b.
165. Sharma, V., Verma, V., Lal, N., Yadav, S.K., Sarkar, S., Mandalapu, D., Porwal, K., Rawat, T., Maikhuri, J.P., Rajender, S., Sharma, V.L., Gupta, G., Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β. Mol. Carcinog. 55 (2016), 1843–1857, 10.1002/mc.22433.
166. Shen, K., Ji, L., Chen, Y., Yu, Q., Wang, Z., Influence of glutathione levels and activity of glutathione-related enzymes in the brains of tumor-bearing mice. Biosci. Trends 5 (2011), 30–37, 10.5582/bst.2011.v5.1.30.
167. Shimura, N., Musya, A., Hashimoto, T., Kojima, S., Kubodera, A., Sasaki, T., Usefulness of 99mTc-d,l-HMPAO for estimation of GSH content in tumor tissues. Nucl. Med. Biol. 27 (2000), 577–580, 10.1016/S0969-8051(00)00131-1.
168. Sun, X., Wang, Q., Wang, Y., Du, L., Xu, C., Liu, Q., Brusatol enhances the radiosensitivity of A549 cells by promoting ROS production and enhancing DNA damage. Int. J. Mol. Sci., 17, 2016, 10.3390/ijms17070997.
169. Suthanthiran, M., Anderson, M.E., Sharma, V.K., Meister, A., Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 3343–3347.
170. Tabaczar, S., Domeradzka, K., Czepas, J., Piasecka-Zelga, J., Stetkiewicz, J., Gwozdzinski, K., Koceva-Chyla, A., Anti-tumor potential of nitroxyl derivative pirolin in the DMBA-induced rat mammary carcinoma model: a comparison with quercetin. Pharmacol. Rep. 67 (2015), 527–534, 10.1016/j.pharep.2014.12.010.
171. Tagde, A., Singh, H., Kang, M.H., Reynolds, C.P., The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma. Blood Cancer J., 4, 2014, e229, 10.1038/bcj.2014.45.
172. Thelander, L., Reichard, P., Reduction of ribonucleotides. Annu. Rev. Biochem. 48 (1979), 133–158, 10.1016/S0079-6603(08)60955-1.
173. Theodossiou, T.A., Olsen, C.E., Jonsson, M., Kubin, A., Hothersall, S., Berg, K., The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy. Redox Biol. 12 (2017), 191–197, 10.1016/j.redox.2017.02.018.
174. Tomasin, R., de Andrade, R.S., Gomes-Marcondes, M.C.C., Oral administration of Aloe vera (L.) Burm. f. (Xanthorrhoeaceae) and honey improves the host body composition and modulates proteolysis through reduction of tumor progression and oxidative stress in rats. J. Med. Food 18 (2015), 1128–1135, 10.1089/jmf.2014.0129.
175. Townsend, D.M., Findlay, V.L., Tew, K.D., Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol. 401 (2005), 287–307, 10.1016/S0076-6879(05)01019-0.
176. Townsend, D.M., Pazoles, C.J., Tew, K.D., NOV-002, a mimetic of glutathione disulfide. Expert Opin. Investig. Drugs 17 (2008), 1075–1083.
177. Townsend, D.M., Tew, K.D., Pharmacology of a mimetic glutathione disulfide, NOV-002. Biomed. Pharmacother. 63 (2010), 75–78, 10.1016/j.biopha.2008.08.019.Pharmacology.
178. Trachootham, D., Alexandre, J., Huang, P., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 8 (2009), 579–591, 10.1038/nrd2803.
179. Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A.L., Pronzato, M.A., Marinari, U.M., Domenicotti, C., Role of glutathione in cancer progression and chemoresistance. Oxid. Med. Cell. Longev. 2013 (2013), 1–10.
180. Utsumi, F., Kajiyama, H., Nakamura, K., Tanaka, H., Mizuno, M., Ishikawa, K., Kondo, H., Kano, H., Hori, M., Kikkawa, F., Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PLoS One 8 (2013), 1–10, 10.1371/journal.pone.0081576.
181. Vanheofer, U., Cao, S., Minderman, H., Toth, K., Skenderis, B.S. II, Slovak, M.L., Rustum, Y.M., D, L-buthionine-(S,R)-sulfoximine in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin. Cancer Res. 2 (1996), 1961–1968.
182. Vanitha, M.K., Priya, K.D., Baskaran, K., Periyasamy, K., Saravanan, D., Venkateswari, R., Mani, B.R., Ilakkia, A., Selvaraj, S., Menaka, R., Geetha, M., Rashanthy, N., Anandakumar, P., Sakthisekaran, D., Taurine regulates mitochondrial function during 7,12-dimethyl benz[a]anthracene induced experimental mammary carcinogenesis. J. Pharmacopunct. 18 (2015), 68–74, 10.3831/KPI.2015.18.027.
183. Venglarik, C.J., Girón-Calle, J., Wigley, A.F., Malle, E., Watanabe, N., Forman, H.J., Hypochlorous acid alters bronchial epithelial cell membrane properties and prevention by extracellular glutathione. J. Appl. Physiol. 95 (2003), 2444–2452.
184. Vergote, I., Finkler, N., del Campo, J., Lohr, A., Hunter, J., Matei, D., Kavanagh, J., Vermorken, J.B., Meng, L., Jones, M., Brown, G., Kaye, S., Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. Eur. J. Cancer 45 (2009), 2324–2332, 10.1016/j.ejca.2009.05.016.
185. Vergote, I., Finkler, N.J., Hall, J.B., Melnyk, O., Edwards, R.P., Jones, M., Keck, J.G., Meng, L., Brown, G.L., Rankin, E.M., Burke, J.J., Boccia, R.V., Runowicz, C.D., Rose, P.G., Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer. Int. J. Gynecol. Cancer 20 (2010), 772–780.
186. Villablanca, J.G., Volchenboum, S.L., Cho, H., Kang, M.H., Cohn, S.L., Anderson, C.P., Marachelian, A., Groshen, S., Tsao-wei, D., Matthay, K.K., Maris, J.M., Hasenauer, C.E., Czarnecki, S., Lai, H., Goodarzian, F., Shimada, H., Reynolds, C.P., A Phase I New approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent / refractory high-risk neuroblastoma. Pediatr. Blood Cancer 63 (2016), 1349–1356, 10.1002/pbc.
187. Vivancos, P.D., Wolff, T., Markovic, J., Pallardó F.V., Foyer, C.H., A nuclear glutathione cycle within the cell cycle. Biochem. J. 431 (2010), 169–178, 10.1042/BJ20100409.
188. Weber, J.S., Samlowski, W.E., Gonzalez, R., Ribas, A., Stephenson, J., O'Day, S., Sato, T., Dorr, R., Grenier, K., Hersh, E., A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma. Cancer 116 (2010), 3683–3691, 10.1002/cncr.25119.
189. Wondrak, G.T., Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid. Redox Signal. 11 (2009), 3013–3069, 10.1089/ars.2009.2541.
190. Wu, B., Dong, D., Human cytosolic glutathione transferases: structure, function, and drug discovery. Trends Pharmacol. Sci. 33 (2012), 656–668, 10.1016/j.tips.2012.09.007.
191. Wu, J.H., Batist, G., Glutathione and glutathione analogues; Therapeutic potentials. Biochim. Biophys. Acta Gen. Subj. 1830 (2013), 3350–3353, 10.1016/j.bbagen.2012.11.016.
192. Yang, H., Jenni, S., Colovic, M., Merkens, H., Poleschuk, C., Rodrigo, I., Miao, Q., Johnson, B.F., Rishel, M.J., Sossi, V., Webster, J.M., 18F-5-Fluoroaminosuberic acid as a potential tracer to gauge oxidative stress in breast cancer models. J. Nucl. Med. 58 (2017), 367–373, 10.2967/jnumed.116.180661.
193. Yang, Y., Zhang, K., Wang, Y., Li, M., Sun, X., Liang, Z., Wang, L., Chen, L., Yang, H., Zhu, L., Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions. Scanning 38 (2016), 825–836, 10.1002/sca.21332.
194. Yellepeddi, V.K., Vangara, K.K., Kumar, A., Palakurthi, S., Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells. Anticancer Res. 32 (2012), 3651–3658.
195. Yi, J., Qu, H., Wu, Y., Wang, Z., Wang, L., Study on antitumor, antioxidant and immunoregulatory activities of the purified polyphenols from pinecone of Pinus koraiensis on tumor-bearing S180 mice in vivo. Int. J. Biol. Macromol. 94 (2017), 735–744, 10.1016/j.ijbiomac.2016.10.071.
196. Yogev, O., Barker, K., Sikka, A., Almeida, G.S., Hallsworth, A., Smith, L.M., Jamin, Y., Ruddle, R., Koers, A., Webber, H.T., Raynaud, F.I., Popov, S., Jones, C., Petrie, K., Robinson, S.P., Keun, H.C., Chesler, L., p53 loss in MYC-driven neuroblastoma leads to metabolic adaptations supporting radioresistance. Cancer Res., 2016, 3025–3036, 10.1158/0008-5472.CAN-15-1939.
197. Zhang, P., Zheng, B.-B., Wang, H.-Y., Chen, J.-H., Liu, X.-Y., Guo, X.-L., DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7 / a cells both in vitro and in vivo. J. Pharm. Pharmacol. 66 (2013), 398–407, 10.1111/jphp.12168.
198. Zhang, T.C., Cao, E.H., Li, J.F., Ma, W., Qin, J.F., Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur. J. Cancer 35 (1999), 1258–1263.
199. Zhang, X.-D., Luo, Z., Chen, J., Song, S., Yuan, X., Shen, X., Wang, H., Sun, Y., Gao, K., Zhang, L., Fan, S., Leong, D.T., Guo, M., Xie, J., Ultrasmall glutathione-protected gold nanoclusters as next generation radiotherapy sensitizers with high tumor uptake and high renal clearance. Sci. Rep., 5, 2015, 8669, 10.1038/srep08669.
200. Zimmermann, A.K., Loucks, F.A., Schroeder, E.K., Bouchard, R.J., Tyler, K.L., Linseman, D.A., Glutathione binding to the Bcl-2 homology-3 domain groove: a MOLECULAR BASIS FOR Bcl-2 ANTIOXIDANT FUNCTION AT MITOCHONDRIA. J. Biol. Chem. 282 (2007), 29296–29304, 10.1016/j.drugalcdep.2008.02.002.A.
201. Zmorzyński, S., Świderska-Kołacz, G., Koczkodaj, D., Filip, A.A., Significance of polymorphisms and expression of enzyme-encoding genes related to glutathione in hematopoietic cancers and solid tumors. Biomed. Res. Int. 2015 (2015), 1–6, 10.1155/2015/853573.